Provider: View Press Release
Type: Link
Title: GSK Board changes | GSK
Description: Elizabeth (Liz) McKee Anderson to join the Board as Non-Executive Director
Provider: View Press Release
Type: Link
Title: US FDA accepts new drug application for GSK’s momelotinib for the treatment of myelofibrosis | GSK
Description: Regulatory submission included data from the pivotal MOMENTUM phase III clinical trial
Provider: View Press Release
Type: Link
Title: Statement: Zantac (ranitidine) U.S. litigation | GSK
Description: Statement regarding U.S. Zantac (ranitidine) litigation
Provider: View Press Release
Type: Link
Title: GSK completes acquisition of Affinivax, Inc. | GSK
Description: GSK today announced it has completed the acquisition of Affinivax, Inc, a clinical-stage biopharmaceutical company based in Cambridge.
Provider: View Press Release
Type: Link
Title: GSK Announces Offer to Repurchase Exchangeable Senior Notes Due 2023 | GSK
Description: GSK Finance (No.3) plc, is offering to repurchase for cash any and all of its outstanding Exchangeable Senior Notes due 2023.
Provider: View Press Release
Type: Link
Title: ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine | GSK
Description: Selected generic manufacturers will have the opportunity to develop, manufacture and supply generic versions of cabotegravir LA for PrEP